DE2644471A1 - Arzneimittel zur behandlung der knoetchenfoermigen brustwarzenentzuendung - Google Patents
Arzneimittel zur behandlung der knoetchenfoermigen brustwarzenentzuendungInfo
- Publication number
- DE2644471A1 DE2644471A1 DE19762644471 DE2644471A DE2644471A1 DE 2644471 A1 DE2644471 A1 DE 2644471A1 DE 19762644471 DE19762644471 DE 19762644471 DE 2644471 A DE2644471 A DE 2644471A DE 2644471 A1 DE2644471 A1 DE 2644471A1
- Authority
- DE
- Germany
- Prior art keywords
- corresponds
- laboratoire
- following formula
- treatment
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010061218 Inflammation Diseases 0.000 title claims description 4
- 230000004054 inflammatory process Effects 0.000 title claims description 4
- 229940126601 medicinal product Drugs 0.000 title description 2
- 210000002445 nipple Anatomy 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 241000186359 Mycobacterium Species 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 239000012876 carrier material Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000004166 Lanolin Substances 0.000 claims description 3
- NBVZMBLJRHUOJR-UHFFFAOYSA-N [amino-[4-[6-[4-[amino(azaniumylidene)methyl]phenoxy]hexoxy]phenyl]methylidene]azanium;2-hydroxyethanesulfonate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 NBVZMBLJRHUOJR-UHFFFAOYSA-N 0.000 claims description 3
- 229960001715 hexamidine isethionate Drugs 0.000 claims description 3
- 229960003350 isoniazid Drugs 0.000 claims description 3
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 3
- 229960000318 kanamycin Drugs 0.000 claims description 3
- 229940039717 lanolin Drugs 0.000 claims description 3
- 235000019388 lanolin Nutrition 0.000 claims description 3
- JUMCEOAAUDKYED-UHFFFAOYSA-N 4-(3-carbamimidoyl-6-phenoxyhexoxy)benzenecarboximidamide Chemical compound C=1C=C(C(N)=N)C=CC=1OCCC(C(=N)N)CCCOC1=CC=CC=C1 JUMCEOAAUDKYED-UHFFFAOYSA-N 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 2
- 229930027917 kanamycin Natural products 0.000 claims description 2
- 229930182823 kanamycin A Natural products 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims 1
- 208000033678 Thelitis Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- UFIYKNIUNRVRSI-UHFFFAOYSA-N hexadecyl octadecyl sulfate;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCCOS(=O)(=O)OCCCCCCCCCCCCCCCC UFIYKNIUNRVRSI-UHFFFAOYSA-N 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7624840A FR2361117A1 (fr) | 1976-08-09 | 1976-08-09 | Preparation medicamenteuse specifique de la thelite nodulaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2644471A1 true DE2644471A1 (de) | 1978-02-16 |
Family
ID=9176890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19762644471 Withdrawn DE2644471A1 (de) | 1976-08-09 | 1976-10-01 | Arzneimittel zur behandlung der knoetchenfoermigen brustwarzenentzuendung |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2644471A1 (enExample) |
| FR (1) | FR2361117A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162361A (en) * | 1990-04-10 | 1992-11-10 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Method of treating diseases associated with elevated levels of interleukin 1 |
-
1976
- 1976-08-09 FR FR7624840A patent/FR2361117A1/fr active Granted
- 1976-10-01 DE DE19762644471 patent/DE2644471A1/de not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162361A (en) * | 1990-04-10 | 1992-11-10 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Method of treating diseases associated with elevated levels of interleukin 1 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2361117B1 (enExample) | 1978-12-15 |
| FR2361117A1 (fr) | 1978-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2707119C2 (enExample) | ||
| DE2331793C3 (enExample) | ||
| DE3013632A1 (de) | Mittel und seine verwendung zur regulierung des knochenmetabolismus | |
| DE3876963T2 (de) | Tablette für Haustiere. | |
| DE2802273C3 (de) | Verfahren zur Herstellung von Suppositorien aus Aminoglycid-Antibiotica | |
| DE60018200T2 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| DE69720952T2 (de) | Behandlungsverfahren für wassertiere und cajeput-öl enthaltende zusammensetzung | |
| DE2644471A1 (de) | Arzneimittel zur behandlung der knoetchenfoermigen brustwarzenentzuendung | |
| DE2062715C3 (de) | Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung | |
| DE2307827A1 (de) | Diaethylpyrocarbonat enthaltender stoff fuer veterinaermedizinische oder kosmetische verwendungszwecke | |
| AT126297B (de) | Verfahren zur Herstellung von den Tonus der Hautblutgefäße hebenden Präparaten. | |
| DE3545201A1 (de) | Synergistische kombination von flupirtin und 4-acetamido-phenol | |
| DE2741599A1 (de) | Mittel zur behandlung von akne vulgaris | |
| DE2408736C2 (de) | Flüssiges Anthelminthicum | |
| DE2262139C2 (de) | Verwendung von Dimethyl-2,2-dichlorvinyl-phosphat zur Bekämpfung der ersten Entwicklungsstufe von Bremsenlarven bei Pferden | |
| EP0710480B1 (de) | Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung | |
| EP2564861B1 (de) | Pharmazeutische Formulierung zur Behandlung von Mastitis bei Säugern | |
| US2280340A (en) | Vermicidal composition | |
| DE3024323A1 (de) | Neue zusammensetzungen fuer die bekaempfung von parasiten warmbluetiger tiere | |
| DE2226927A1 (de) | Gegen fettsucht und cellulitis wirksame zusammensetzung und verabreichungsform derselben | |
| DE2934090A1 (de) | Therapie der hyperkeratotischen hauterkrankungen. | |
| DE879007C (de) | Verfahren zur Gewinnung von Bienenprodukten honigartiger Konsistenz mit besondere Wirkung | |
| DD280037A5 (de) | Verfahren zur herstellung von tieraerztlichen stoffen, vorzugsweise geeignet fuer die behandlung von mastitis | |
| DE2537202A1 (de) | Parasitizides praeparat | |
| DE550833C (de) | Verfahren zur UEberfuehrung von Bakterienpraeparaten, Bakterienextrakten, Toxinen, Sera u. dgl. in haltbare, die Haut und die Schleimhaeute leicht durchdringende Produkte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OAP | Request for examination filed | ||
| OD | Request for examination | ||
| 8139 | Disposal/non-payment of the annual fee |